Strategic Changes in Medicare Advantage Enrollment Growth

Medicare Advantage (MA) enrollment is experiencing slower growth, signaling strategic changes among major U.S. insurers. By February, MA plans covered around 35.5 million individuals, an increase from approximately 34.4 million the previous year, reflecting a 3% growth rate. This marks a significant reduction from the double-digit annual increases that were once common in the program.

Large insurers are adjusting due to rising medical costs, regulatory shifts, and diminishing profit margins. An analysis of the latest CMS data reveals insurers refining their MA offerings by withdrawing from specific markets and eliminating less profitable members during the latest open enrollment period. The strategic scaling back aims to adapt to evolving regulatory compliance requirements and financial pressures.

UnitedHealthcare, the leading MA provider, reported a membership decrease, with figures dropping from 10.3 million to just under 9.4 million by February. Other prominent insurers like Elevance, Centene, and CVS Health’s Aetna division also saw reductions in their MA enrollment figures. For example, CVS Health’s coverage fell from 4.2 million members to slightly over 4 million.

In contrast, Humana expanded its MA membership, adding over 1 million members and increasing its enrollees to above 7 million. This aggressive growth strategy positions Humana to potentially overtake UnitedHealthcare as the largest MA provider, although financial projections suggest lower-than-expected earnings. Meanwhile, Kaiser Permanente reported a modest growth of 1% in MA enrollment to around 2 million members.

Smaller and mid-sized companies capitalized on these industry changes. Devoted Health more than doubled its membership to nearly 470,000, while Alignment Health grew by 21% to almost 280,000 members. Regional plans like SCAN Group and CareSource also saw membership gains, indicating a dynamic shift in the competitive landscape.

Amid these shifts, UnitedHealth, Humana, and CVS maintain dominant positions, with the MA market serving over half of all Medicare beneficiaries. Nevertheless, further industry changes are on the horizon. An approaching MA open enrollment period and potential future payment policy adjustments contribute to ongoing uncertainty, while regulatory bodies heighten scrutiny over risk adjustment procedures and conduct audits concerning coding practices and potential overpayments.

The era of rapid MA expansion might be drawing to a close. Upcoming challenges will compel insurers to balance growth, profitability, and regulatory compliance within an increasingly restrictive environment. These developments underscore a pivotal moment for the MA sector as it adapts to a new phase of measured growth and heightened oversight.